LENZ Therapeutics Inc

The current institutional shareholding score of LENZ Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 115.82%, representing a quarter-over-quarter increase of 6.75%. The largest institutional shareholder is Steven Cohen, holding a total of 1.20M shares, representing 3.25% of shares outstanding, with 1.00% increase in holdings.